Results 281 to 290 of about 749,314 (382)
Establishment and characterization of a human myeloid cell line from Philadelphia chromosome-negative myeloblastic leukemia arising in a patient with myelodysplastic syndrome [PDF]
TM McCarty+4 more
openalex +1 more source
New anticancer therapies with potential cardiovascular side effects are continuously being introduced into clinical practice, with new and often unexpected toxicities becoming apparent only after clinical introduction. These unknown toxicities should be identified and understood beforehand to better prepare patients and physicians, enabling the ...
Alessandra Ghigo+22 more
wiley +1 more source
The Role of the Sirtuin Family Histone Deacetylases in Acute Myeloid Leukemia-A Promising Road Ahead. [PDF]
Strzałka P+7 more
europepmc +1 more source
The epigenetic role of EZH2 in acute myeloid leukemia. [PDF]
Fang J, Zhang J, Zhu L, Xin X, Hu H.
europepmc +1 more source
Assessment of chromatin remodeling of acute myeloid leukemia cells treated with gilteritinib: a case report. [PDF]
Mori J+6 more
europepmc +1 more source
Long noncoding RNAs in acute myeloid leukemia: biomarkers, prognostic indicators, and treatment potential. [PDF]
Farajzadeh M+6 more
europepmc +1 more source
Synthetic Biology‐Based Engineering Cells for Drug Delivery
Synthetic biology‐based therapeutic cells for drug delivery: Engineered cells effectively transport and release drugs through their intelligence and controllability, such as feedback pathways and external stimuli (e.g., light and ultrasound). The integration of nanotechnology, including nanoparticles, biofilms, and artificial cells, enhances ...
Wenzhe Yi+4 more
wiley +1 more source
Mitochondrial abnormalities as a target of intervention in acute myeloid leukemia. [PDF]
Tjahjono E+4 more
europepmc +1 more source